Page last updated: 2024-10-19

phenylacetic acid and Chronic Illness

phenylacetic acid has been researched along with Chronic Illness in 3 studies

phenylacetic acid : A monocarboxylic acid that is toluene in which one of the hydrogens of the methyl group has been replaced by a carboxy group.

Research Excerpts

ExcerptRelevanceReference
"Experimental allergic encephalomyelitis (EAE) is the animal model for multiple sclerosis."1.32Sodium phenylacetate inhibits adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice at multiple steps. ( Banik, NL; Dasgupta, S; Jana, M; Pahan, K; Zhou, Y, 2003)
"Leptin treatment had no effect on plasma lipid profile and glucose level."1.32Leptin decreases plasma paraoxonase 1 (PON1) activity and induces oxidative stress: the possible novel mechanism for proatherogenic effect of chronic hyperleptinemia. ( Bełtowski, J; Jamroz, A; Wójcicka, G, 2003)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dasgupta, S1
Zhou, Y1
Jana, M1
Banik, NL1
Pahan, K1
Bełtowski, J1
Wójcicka, G1
Jamroz, A1
Davis, BA1
Yu, PH1
Carlson, K1
O'Sullivan, K1
Boulton, AA1

Other Studies

3 other studies available for phenylacetic acid and Chronic Illness

ArticleYear
Sodium phenylacetate inhibits adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice at multiple steps.
    Journal of immunology (Baltimore, Md. : 1950), 2003, Apr-01, Volume: 170, Issue:7

    Topics: Acute Disease; Administration, Oral; Adoptive Transfer; Animals; Anti-Inflammatory Agents, Non-Stero

2003
Leptin decreases plasma paraoxonase 1 (PON1) activity and induces oxidative stress: the possible novel mechanism for proatherogenic effect of chronic hyperleptinemia.
    Atherosclerosis, 2003, Volume: 170, Issue:1

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Antimetabolites, Antineoplastic; Antioxidan

2003
Plasma levels of phenylacetic acid, m- and p-hydroxyphenylacetic acid, and platelet monoamine oxidase activity in schizophrenic and other patients.
    Psychiatry research, 1982, Volume: 6, Issue:1

    Topics: Antipsychotic Agents; Blood Platelets; Chronic Disease; Humans; Intellectual Disability; Monoamine O

1982